Clinical Trial Update: Denervation of the REnal Artery in Metabolic Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating renal denervation for metabolic syndrome has completed, assessing effects on insulin resistance and blood pressure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Insulin Resistance
• Metabolic Syndrome

Snippet

Sponsor: UMC Utrecht | Conditions: Insulin Resistance, Blood Pressure | Phase 3 | Status: COMPLETED